Zobrazeno 1 - 10
of 511
pro vyhledávání: '"Boris, Hadaschik"'
Autor:
Kevin Claaßen, Madeleine Karpinski, Hiltraud Kajüter, Johannes Hüsing, Lennart Möller, Ina Wellmann, Viktor Grünwald, Boris Hadaschik, Peter Albers, Andreas Stang
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The crude mortality rate and the lifetime mortality risk from prostate cancer in Germany are above international average. However age-standardised mortality and years of life lost per capita from prostate cancer are declining. Thi
Externí odkaz:
https://doaj.org/article/c63f78473323475196a6089bc91729ea
Autor:
Melinda Váradi, Orsolya Horváth, Orsolya Módos, Tamás Fazekas, Camilla M. Grunewald, Günter Niegisch, Ulrich Krafft, Viktor Grünwald, Boris Hadaschik, Csilla Olah, Anikó Maráz, Andrea Furka, Miklós Szűcs, Péter Nyirády, Tibor Szarvas
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Clinical trials revealed significant antitumor activity for immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC). Due to their strict eligibility criteria, clinical trials include selected patient cohorts, and thus do
Externí odkaz:
https://doaj.org/article/1a068853788840639a37f8acf3d9283b
Publikováno v:
Diagnostics, Vol 14, Iss 8, p 853 (2024)
Introduction: To predict early continence recovery following radical prostatectomy (RP) using baseline demographic and clinical data, as well as dynamic transperineal ultrasound (TPUS) parameters of membranous urethral length (MUL). Patients and Meth
Externí odkaz:
https://doaj.org/article/6e9e07859305473f90b035c7e3473fa9
Autor:
Melinda Varadi, Nikolett Nagy, Henning Reis, Boris Hadaschik, Christian Niedworok, Orsolya Modos, Attila Szendroi, Jason Ablat, Peter C. Black, David Keresztes, Anita Csizmarik, Csilla Olah, Nadine T. Gaisa, Andras Kiss, Jozsef Timar, Erika Toth, Erzsebet Csernak, Arpad Gerstner, Vinay Mittal, Sofia Karkampouna, Marianna Kruithof de Julio, Balazs Gyorffy, Gabor Bedics, Michael Rink, Margit Fisch, Peter Nyirady, Tibor Szarvas
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 9041-9054 (2023)
Abstract Objective Administration of targeted therapies provides a promising treatment strategy for urachal adenocarcinoma (UrC) or primary bladder adenocarcinoma (PBAC); however, the selection of appropriate drugs remains difficult. Here, we aimed t
Externí odkaz:
https://doaj.org/article/e41fec3667254bd390a37fade443482d
Autor:
Yang Liu, Katharina Lueckerath, Jason Hughes, Wolfgang Peter Fendler, Ken Herrmann, Alexander Hakansson, Analena Handke, Claudia Kesch, Tugce Telli, Elai Davicioni, Hong Song, Boris Hadaschik, Robert Seifert
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Rationale 177Lu-PSMA ([177Lu]Lutetium-PSMA-617) therapy is an effective treatment option for patients with prostate specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer, but still shows a non-responder rate of app
Externí odkaz:
https://doaj.org/article/b6e2f176f67a4c6e8b5ba00ed2930544
Autor:
Csilla Olah, Henning Reis, Michèle J. Hoffmann, Fabian Mairinger, Saskia Ting, Boris Hadaschik, Ulrich Krafft, Viktor Grünwald, Peter Nyirady, Melinda Varadi, Balázs Győrffy, Andras Kiss, Eszter Szekely, Gottfrid Sjödahl, Tibor Szarvas
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5222-5232 (2023)
Abstract Objective Although targeted approaches have become available in second‐ and third‐line settings, platinum‐based chemotherapy remains the standard first‐line treatment for advanced muscle‐invasive bladder cancer (MIBC). Therefore, t
Externí odkaz:
https://doaj.org/article/7547c69a833c47a98b4d560264ca3735
Autor:
Dalia Ahmad Khalil, Jörg Wulff, Danny Jazmati, Dirk Geismar, Christian Bäumer, Paul-Heinz Kramer, Theresa Steinmeier, Stefanie Schulze Schleithoff, Stephan Tschirdewahn, Boris Hadaschik, Beate Timmermann
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 758-768 (2023)
Background: The aim of this study is to examine the dosimetric influence of endorectal balloons (ERB) on rectal sparing in prostate cancer patients with implanted hydrogel rectum spacers treated with dose-escalated or hypofractionated intensity-modul
Externí odkaz:
https://doaj.org/article/82748379d39740a7a5d9783a25d237d7
Autor:
Christoph Pöttgen, Christian Hoffmann, Thomas Gauler, Maja Guberina, Nika Guberina, Toke Ringbaek, Alina Santiago Garcia, Ulrich Krafft, Boris Hadaschik, Aymane Khouya, Martin Stuschke
Publikováno v:
Cancers, Vol 15, Iss 20, p 4933 (2023)
Online adaptive radiotherapy (ART) allows adaptation of the dose distribution to the anatomy captured by with pre-adaptation imaging. ART is time-consuming, and thus intra-fractional deformations can occur. This prospective registry study analyzed th
Externí odkaz:
https://doaj.org/article/e6baeeb532b54e94b0c95549840eea92
Autor:
Dalia Ahmad Khalil, Danny Jazmati, Dirk Geismar, Jörg Wulff, Christian Bäumer, Paul Heinz Kramer, Theresa Steinmeier, Stefanie Schulze Schleitthoff, Sandija Plaude, Martin Bischoff, Stephan Tschirdewahn, Boris Hadaschik, Beate Timmermann
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Purpose To examine the dosimetric feasibility of hypofractionated/dose escalated radiation therapy in patients with localized prostate carcinoma using simultaneous integrated boost intensity-modulated proton beam therapy (SIB-IMPT) in absenc
Externí odkaz:
https://doaj.org/article/28b4f3d01a0a44228e096e039e408cfb
Autor:
Jeremie Calais, Shaojun Zhu, Nader Hirmas, Matthias Eiber, Boris Hadaschik, Martin Stuschke, Ken Herrmann, Johannes Czernin, Amar U. Kishan, Nicholas G. Nickols, David Elashoff, Wolfgang P. Fendler
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background Definitive radiation therapy (dRT) is an effective initial treatment of intermediate-risk (IR) and high-risk (HR) prostate cancer (PCa). PSMA PET/CT is superior to standard of care imaging (CT, MRI, bone scan) for detecting region
Externí odkaz:
https://doaj.org/article/870c6b89399248c18205fcf9f3ba24e4